Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Ras-Raf-MAPK-ERK > MEK (MAP2K)

Vacquinol-1

  Cat. No.:  DC8473   Featured
Chemical Structure
5428-80-8
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
Get Quotation Now
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Vacquinol-1 is an activator of MKK4-dependent macropinocytotic cell death in glioblastoma cells.
Chemicals PropertiesBiological activity COA & MSDSRelated productsDatasheet
Cas No.: 5428-80-8
Chemical Name: Vacquinol-1
Synonyms: 4-Quinolinemethanol,2-(4-chlorophenyl)-a-2-piperidinyl-;[2-(4-chlorophenyl)quinolin-4-yl]-(2-piperidyl)methanol;[2-(4-chlorophenyl)quinolin-4-yl]-piperidin-2-ylmethanol;Vacquinol-1;(2-(4-chlorophenyl)-4-quinolinyl)(2-piperidinyl)methanol;(2-(4-chlorophenyl)quinolin-4-yl)(piperidin-2-yl)methanol;[2-(4-chloro-phenyl)-[4]quinolyl]-[2]piperidyl-methanol;[2-(4-chlorophenyl)quinolin-4-yl](piperidin-2-yl)methanol;[2-(4-Chlor-phenyl)-[4]chinolyl]-[2]piperidyl-methanol;AC1L5DG6;AC1Q3NLM;NSC13316;SureCN8738855
SMILES: C1=CC=C2C(=C1)C(=CC(=N2)C3=CC=C(C=C3)Cl)C(C4CCCCN4)O
Formula: C21H21N2OCl
M.Wt: 352.85724
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: Vacquinol-1 is an activator of MKK4-dependent macropinocytotic cell death in glioblastoma cells.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
2018-0101
Cat. No. Product name Field of application
DC7488 RO4987655 RO4987655(CH-4987655) is an orally active small molecule, targeting mitogen-activated protein kinase kinase 1 (MAP2K1/MEK1 IC50=5.2 nM), with potential antineoplastic activity.
DC8473 Vacquinol-1 Vacquinol-1 is an activator of MKK4-dependent macropinocytotic cell death in glioblastoma cells.
DC7243 U0126 U0126-EtOH(U-0126) is a highly selective inhibitor of MEK1/2 with IC50 of 0.07 μM/0.06 μM, 100-fold higher affinity for ΔN3-S218E/S222D MEK than PD098059.
DC1099 Trametinib Trametinib is a highly specific and potent MEK1 and MEK2 inhibitor with IC50 of 0.92 nM and 1.8 nM, respectively.
DC7308 TAK-733 TAK-733 is a potent and selective MEK allosteric site inhibitor for MEK1 with IC50 of 3.2 nM, inactive to Abl1, AKT3, c-RAF, CamK1, CDK2, c-Met, etc.
DC7808 Refametinib (BAY86-9766) Refametinib (RDEA119, Bay 86-9766) is a potent, ATP non-competitive and highly selective inhibitor of MEK1 and MEK2 with IC50 of 19 nM and 47 nM, respectively.
DC1056 PD0325901 (Mirdametinib) PD0325901 (PD325901) is selective and non ATP-competitive MEK inhibitor with IC50 of 0.33 nM.
DC5100 PD 98059 PD 98059 is a selective inhibitor of MEK and blocker of MAPK
DC7723 OTS964， OTS 964 OTS964 is a novel TOPK(T–lymphokine-activated killer cell–originated protein kinase) inhibitor.
DC4177 Cobimetinib(GDC-0973; XL518) GDC-0973 is a potent, highly selective inhibitor of mitogen-activated protein kinase kinase, also known as MEK, a serine/threonine kinase that is a component of the RAS/RAF/MEK/ERK pathway.
X
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Site Map|Privacy PolicyCopyright © 2018-2020 All Rights Reserved. Technical Support:KuuJia